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images but also underline the need for harmonizing image resolution 
and data analysis methodology to ensure harmonized quantitative 
performance across multiple sites.  
This lecture will focus on the impact and interplay of image resolu-
tion, noise and data collection and analysis methodology on the 
various ways of PET tracer uptake quantification. Moreover, the 
impact of relatively new PET technologies, such as time of flight 
technology and new image reconstruction algorithm, on the accuracy 
and precision of tracer uptake quantification will be addressed. 
Finally, based on the first results obtained from the EARL accredita-
tion program, the feasibility and need for a central QA/QC accredita-
tion program will be discussed. 
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The role of positron emission tomography (PET) scanning in radiation 
oncology has evolved as it is the most specific and sensitive means of 
imaging fundamental aspects of tumour biology.  
PET has been applied in different RT procedures: correct staging and 
optimal treatment strategy, accurate delineation of biological target 
volume (BTV) for treatment planning, prediction of  tumor response, 
evaluation of  healthy tissue function after radiotherapy. 
In the era of high-precision radiotherapy, accurate tumor volume 
delineation regarding tumor boundaries, shape and volume is crucial. 
Quite different approaches have been used for target volume delinea-
tion on PET images: the anatomic sites of the pathologic zones on  
PET scan were delineated on CT scan, absolute/relative thresholding 
algorithms, complex algorithms (i.e. gradient/statistical based me-
thods). 
The introduction of the combined PET/CT imaging modalities into 
routine clinical RT practice has promise to be of great clinical signific-
ance in the accurate delineation of RT target volume in the treatment 
of cervix, head and neck, and lung cancers.  
The overall sensitivity, specificity and accuracy of FDG-PET for detec-
tion of lung cancers are very high for primary, residual and recurrent 
disease; contour guided by FDG-PET/CT led to significant modification 
of treatment strategy and radiotherapy planning in NSCLC patients. A 
limiting factor to the accuracy of target volume definition by PET/CT 
is organ and tumor motion, which is mainly due to the patient respira-
tion. Motion management is thus becoming an important issue in both 
diagnostic and RT applications, particularly when PET/CT images are 
used for tumor delineation; within this contest 4D techniques provide 
information which can be used to improve/personalize volume defini-
tion and treatment planning strategy.  
Careful comparison of FDG-PET, MRI and CT scans with the histopa-
thology of resented tumor specimens shows is the most accurate of 
the three for the detection of head and neck cancer.  
PET images are used for tumor detection and delineation, however 
such images may also contain information on the spatial distribution 
of factors influencing tumor radiosensitivity (hypoxia, proliferation) 
and a few studies have used PET in biologic image-guided dose escala-
tion to the radioresistant BTV using IMRT. This use of PET imaging in 
combination with dose escalation is of great interest in tumor sites 
such as head-and-neck and the prostate. 
 
 SYMPOSIUM: DOSIMETRY OF LOW AND MEDIUM 
ENERGY PHOTON BEAMS IN RADIOTHERAPY  
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Kilovoltage x-rays are something of a Cinderella subject in radiothera-
py physics although accurate absolute dosimetry is perhaps more 
challenging than for megavoltage beams.   
The first step is to determine the energy/quality of the beam.  This is 
usually done in terms of the first half value layer (HVL) measured 
under narrow beam conditions.  In order to fully characterise the 
energy spectrum the generating kV is also needed and TG-61 shows 
that there is wide variation in the HVL for the same generating poten-
tial.  The IAEA defines low energy as up to a generating potential of 
100 kV or 3 mm of Al HVL and medium energy as starting at 80kV or 
2mm of Al.  The IPEM defined an additional very low energy band from 
0.035 mm of Al up to 1 mm (8-50kV) with low energy considered as up 
to 160kV. 
Most standards laboratories offer only an air kerma calibration based 
on ionometry, but PTB also has a calorimetric standard. The IAEA 
TRS398 code of practice offers a formalism for the use of a calibration 
factor defined in terms of absorbed dose to water and suggests that 
standards laboratories that offer only an air kerma calibration could 
also provide calibrations in terms of absorbed dose to water by apply-
ing an appropriate air kerma code of practice.  In IAEA TECDOC1455 
comparing TRS398 to air kerma based codes of practice differences of 
up to 4% were found for low energies but agreement was within 1% for 
medium energies. 
There are two ways in which the output of the machine can then be 
measured: a measurement of air kerma in air together with the 
application of a backscatter factor or a calibration at a relevant depth 
in a phantom.  In the latter case a perturbation correction is needed.  
The magnitude of these corrections is calculated using Monte Carlo 
methods.  Changes to codes of practice of around 7% (at 100kV) have 
been required (IAEA TRS277 and IPEMB revision 2005). The consensus 
seems to be that measurement at 20 mm depth in water is the pre-
ferred approach for medium energy x-rays but codes of practice are 
divided about whether measurements at very low energy (40kV) 
should be in air (e.g. TG61) or a phantom (e.g. IPEMB).  There is 
general agreement that plastic phantoms need to be used with care. 
Newer devices such as the Zeiss Intrabeam device and the Ariane 
Papillon machine use 50kV x-rays with more challenging geometries.  
For these devices special jigs are needed to ensure geometric accura-
cy and GafChromic EBT2 film may also offer an appropriate means of 
reference dosimetry especially for small fields.  For low energies the 
requirement for controlled geometry suggests the use of plastic 
phantoms but for medium energies the use of liquid water reduces 
uncertainty. 
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Purpose/Objective: The Monte Carlo method is the most accurate 
method for radiation measurement simulation and dose calculation. 
This presentation reviews the recent advances of Monte Carlo for low 
and medium energy x-ray beam modeling. 
Material/methods: In the last 20 years significant developments have 
been made in the areas of radiation transport theory, Monte Carlo 
simulation techniques and computer technology, which have enabled 
the Monte Carlo method for widespread applications in radiation 
measurement and clinical radiotherapy dosimetry. Kilovoltage x-rays 
are different from megavoltage x-rays due to their excessive scatter-
ing properties and short electron ranges,which make it possible to 
simulate photon transport only in some Monte Carlo applications such 
as brachytherapy dose calculation.  
Results: We will first start with the Monte Carlo modeling of the air-
filled ionization chamber response in low and medium energy x-ray 
beams where the fractional contributions of the secondary electrons 
from the cavity air and the surrounding chamber media were investi-
gated accurately. This will be followed by Monte Carlo studies of 
ionization chamber corrections factors for the chamber stem and 
waterproofing sheath that demonstrated the accuracy and efficiency 
of Monte Carlo simulations of the photon attenuation and scattering 
effects with the use of correlated sampling techniques. More detailed 
reviews of the Monte Carlo method for radiotherapy dosimetry and 
treatment planning will be given with a focus on radiation source 
modeling, kilovoltage CT dose calculation, and treatment planning 
dose calculation for external beam therapy and brachytherapy.   
Conclusion: The Monte Carlo method has been demonstrated as a 
useful simulation tool for accurate dosimetry measurement and 
radiotherapy dose calculation. 
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X-ray beams with peak energies ranging from around 50 to 300 kilo-
volts were in widespread use until the end of the 1950s when Cobalt 
60 gamma rays and accelerator produced megavoltage x rays took 
over due to their much greater penetrating power. However, almost 
all of our knowledge of (cellular) radiobiology has been derived from 
irradiating cells with kilovoltage x ray sources, for reasons of cost and 
practicability. It is therefore essential that we do not forget about 
their radiobiological properties, even if such radiation qualities play 
only a minor role in today's radiotherapy. Furthermore, the differenc-
es in cell killing between kilovoltage and megavoltage photons (and 
electrons) per unit dose have a great deal to teach us about the 
fundamental mechanisms of the biological effect of radiation. 
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Essentially the same general radiobiological considerations apply to 
kilovoltage as to megavoltage x rays i.e. cell killing is adequately 
described by the linear-quadratic model, and for (most) tumour 
types we expect a higher α/β than for normal tissues thus making 
fractionation theoretically advantageous. However, given the ex-
tremely rapid fall-off of dose with depth, and the fact that today only 
superficial tumours are treated with kilovoltage beams, the dose to 
any underlying normal tissues will inevitably be very low and may 
therefore pose a negligible complication risk. This enables large 
fractions to be used. 
Megavoltage therapy was already well established when computer 
planning systems first came on the scene in the 1970s. Naturally all 
the effort went into developing algorithms for computing dose in 
patients from such beams and consequently no treatment planning 
systems model kilovoltage beams. The very large amount of (photon) 
scatter, which gives rise to a build-up of dose at small depths, would 
pose quite a challenge for algorithm developers, though secondary 
electron transport can be ignored as the low initial electron ener-
gies result in largely sub-millimetre ranges in tissue. We have created 
a simple 250 kV x-ray plan for a lung tumour using the GEANT Monte-
Carlo code in order to compare the DVHs to those derived from a 
megavoltage plan. For one particular NSCLC patient, treated with 6 
MV x rays, this comparion has yielded 0% TCP for the kV plan for the 
same 9.5% lung pneumonitis NTCP as for the MV plan. Increasing the 
NTCP to 15% for both plans (i.e. by winding up the MUs) has yielded 
TCPs of 94.6% for the MV plan against 1.9% for the kV plan. However, 
this was for a realtively large tumour.   
It can be noted that kilovoltage therapy is undergoing a renais-
sance through 50 kV 'Papillon' contact therapy for rectal tumours.     
   
 SYMPOSIUM: IMPROVING ACCURACY IN IGRT TREAT-
MENT DELIVERY  
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Purpose: Accuracy in patients positioning with novel irradiation 
techniques, which allow tight conformation of dose distribution, is of 
great interest in image guided radiotherapy (IGRT) era.  
Material and methods: Several studies have examined the relevance 
and the magnitude of rotational set up errors, using portal image 
registration, serial CT scans or recently employing kilovoltage cone-
beam CT (CBCT). They demonstrated that in prostate, head & neck 
and thoracic cancer, rotational errors are small in magnitude but 
statistically significant and that their magnitude is not correlated with 
the magnitude of the translational set up errors. Morevover several 
authors demonstrated that online correction of rotation can improve 
target coverage because rotational shift could have an impact on dose 
distribution, varying according to treatment site and to radiation 
techniques. Therefore an approach to improving accuracy of patient 
positioning is to develop devices that permit couch movement with 
6°of freedom (6DOF). In our centre the ProturaTM Robotic Patient 
Positioning System (CIVCO Medical Solution) was installed onto a 
Linear accelerator (Varian Medical System). We started a study to 
evaluate therelevance of rotational shift in IGRT and to validate the 
added value of  6DOF robotic couch to  improve setup accuracy with 
the Cone Beam CTscanner (CBCT). The radiation therapist and techni-
cians were instructed to use the system and, through daily use, de-
termined the best application of the system. 
Results: Guckenberger et al. found a rotational error >2° in 3.7% of 
pelvic tumors, 26.4% of thoracic tumors and 12,4% of head and neck 
tumors; the corresponding maximal rotational errors were 5° , 8° and 
6°. Kaiser et al. observed in 96.6% of prostate and head and neck 
cancer a rotational correction <4°, with no difference between week 
1 and 4 of treatment; a smaller pitch variation but a larger yaw 
variation were recorded in head and neck. Concerning dosimetric 
results,  Guckenberger et al. observed a decreased target coverage 
and an highly increased dose to the organat at risk (OAR) when elon-
gated target volume and sharp dose gradients were adjacent to OAR. 
Lang et al. observed a reduction of target coverage for pitch of 3° 
with no differences between dorsal o ventral direction. In our centre 
from October to December 2012, 5 prostate and 3 H&N patients were 
enrolled. The magnitude of roll variation was  greater in both groups 
(mean (±SD) of -0.5±1.2° in prostate and a maximal value of 3.8° and 
a mean (±SD) of 1.3±1,2 ° in H&N with a maximal value of 3.4°). The 
pitch variations were greater for patients treated to the pelvis (means 
(±SD) of -0.4±1.1° vs -0.1±0.8° with a maximal value of 2.8° vs 1.9°), 
while the mean (±SD) interfractional yaw was 0.1±0.7° in prostate and 
0.0±0.6° in H&N patients. No correlation was observed between the 
magnitude of translational and rotational shift in either group. The 
online correction using CBCT studies added less than one minute to 
the treatment time when compared to IGRT without robotic 6DOF 
couch. 
Conclusions: These data confirm the relevance of rotational shift and 
the feasibility of using a robotic 6 DOFcorrection table in routine 
radiotherapy. In our centre correlation between volumetric and 
geometrical shift data and evaluation of its dosimetrical impact on 
adaptive dose is ongoing.  
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This presentation discusses an ongoing project lead by members of the 
ESTRO RTT Committee on the Development of guidelines for set up 
and verification requirements in head and neck radiotherapy.  This is 
the first set of ESTRO guideline to be developed by RTTs. 
The presentation will give the background as to why ESTRO develops 
guidelines for its members, the rationale for the selection of this topic 
and the progress to date. 
The methodology for the project includes an extended literature 
review, the development of an online questionnaire and its translation 
and distribution to RTTs throughout Europe as well as case reports 
from selected clinical departments across Europe. 
The results of the extended literature review will be presented, along 
with the preliminary results of the questionnaire and the focus of the 
case reports will be discussed.  
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Irradiation of bladder cancer is challenging since the variable and 
deformable bladder and bowel filling makes the target highly mobile. 
Traditionally, large target margins (up to several cm) are applied with 
the high dose area comprising the full range of bladder filling. Innova-
tions were enabled by the introduction of Cone Beam CT (CBCT) 
during the last decade.  
A challenge for image guided radiotherapy is that the tumor on the 
bladder wall is difficult to delineate on planning CT and not visible at 
all on CBCT. Several procedures are developed to demarcate the 
tumor, using cystoscopy. For instance, the contrast liquid lipiodol is 
successfully injected in the bladder wall to locate the tumor using a 
flexible scope. Lipiodol markers are well visible on CT for guiding 
target delineation. Moreover, markers are also visible on CBCT during 
the whole treatment course enabling daily target localization. 
The visibility of the target on CBCT in combination with a rather well 
visible bladder wall enabled application of adaptive radiotherapy 
(ART) procedures. Currently reported ART procedures are variations 
on the following scheme: 
 Acquisition of planning CTs with varying bladder filling (typically 
a full and empty bladder). 
 Creation of a number of 'additional bladders', with interpolated 
(or also extrapolated) volumes. 
 Design of plans-of-the-day (PDs) for each bladder volume. 
 Treatment with daily CBCT acquisition. 
 Patient repositioning, based on bony anatomy or tumor markers. 
 Based on the amount of bladder filling the correct PD is selected 
and delivered. 
This approach has shown to enable a significant reduction of the 
target margins and sparing of organs-at-risk like the small bowel and 
healthy part of the bladder. 
One of the challenges for clinical introduction of ART is the PD selec-
tion. This selection is based on the bladder volume. It is possible to 
automate the bladder delineation on CBCT. An approach with a 
'restricted bladder shape' has been investigated, fitting the shape on 
the grey value gradient of the CBCT image. As final check, the auto-
matically obtained bladder shape can be corrected manually. This 
approach turned out to be effective in selecting the correct PD and 
corresponds in 81% with the manually chosen PD.  
To report the actually given dose to each daily deformed target and 
bladder shape, the daily dose must be accumulated. It requires an 
anatomically correct deformable registration, defining the corres-
